{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:59:38Z","timestamp":1786982378975,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s12325-022-02308-w","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T05:03:10Z","timestamp":1664427790000},"page":"19-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identifying Patients for Self-Administration of Omalizumab"],"prefix":"10.1007","volume":"40","author":[{"given":"Kevin R.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonya","family":"Winders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandy","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Millette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley E.","family":"Chipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"2308_CR1","unstructured":"Xolair Prescribing Information. South San Francisco, California: Genentech, Inc. 2021."},{"key":"2308_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40259-018-0295-0","volume":"32","author":"B Bittner","year":"2018","unstructured":"Bittner B, Richter W, Schmidt J. Subcutaneous administration of biotherapeutics: an overview of current challenges and opportunities. BioDrugs. 2018;32:425\u201340.","journal-title":"BioDrugs"},{"key":"2308_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/193229680800200319","volume":"2","author":"JE Thurman","year":"2008","unstructured":"Thurman JE. Analysis of insulin pen devices for the treatment of diabetes mellitus. J Diabetes Sci Technol. 2008;2:482\u20133.","journal-title":"J Diabetes Sci Technol"},{"key":"2308_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/14712598.2017.1309390","volume":"17","author":"MP Sparrow","year":"2017","unstructured":"Sparrow MP. Adalimumab in ulcerative colitis-efficacy, safety and optimization in the era of treat-to target. Expert Opin Biol Ther. 2017;17:613\u201321.","journal-title":"Expert Opin Biol Ther"},{"key":"2308_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s40744-017-0080-4","volume":"4","author":"M Schiff","year":"2017","unstructured":"Schiff M, Saunderson S, Mountian I, Hartley P. Chronic disease and self-injection: ethnographic investigations into the patient experience during treatment. Rheumatol Ther. 2017;4:445\u201363.","journal-title":"Rheumatol Ther"},{"key":"2308_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/jdv.13768","volume":"31","author":"K Callis Duffin","year":"2017","unstructured":"Callis Duffin K, Bagel J, Bukhalo M, et al. Phase 3, open-label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate-to-severe plaque psoriasis (UNCOVER-A). J Eur Acad Dermatol Venereol. 2017;31:107\u201313.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2308_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jdin.2020.06.004","volume":"1","author":"M Ito","year":"2020","unstructured":"Ito M, Kamata M, Uchida H, et al. Introduction of self-injection increases compliance with dupilumab administration in adult patients with atopic dermatitis: a single-center retrospective study. JAAD Int. 2020;1:91\u20132.","journal-title":"JAAD Int"},{"key":"2308_CR8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/humrep\/deg234","volume":"18","author":"P Platteau","year":"2003","unstructured":"Platteau P, Laurent E, Albano C, et al. An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF\/ICSI. Hum Reprod. 2003;18:1200\u20134.","journal-title":"Hum Reprod"},{"key":"2308_CR9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1080\/17425247.2017.1243526","volume":"14","author":"TR Rohrer","year":"2017","unstructured":"Rohrer TR, Horikawa R, Kappelgaard AM. Growth hormone delivery devices: current features and potential for enhanced treatment adherence. Expert Opin Drug Deliv. 2017;14:1253\u201364.","journal-title":"Expert Opin Drug Deliv"},{"key":"2308_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/ACI.0000000000000656","volume":"20","author":"C Lombardi","year":"2020","unstructured":"Lombardi C, Bagnasco D, Passalacqua G. Biological agents for severe asthma: the evolution of the at-home self-injection approach. Curr Opin Allergy Clin Immunol. 2020;20:421\u20137.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2308_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/14712598.2021.1882990","volume":"21","author":"F Menzella","year":"2021","unstructured":"Menzella F, Ferrari E, Ferrucci SM, et al. Self-administration of omalizumab: why not? A literature review and expert opinion. Expert Opin Biol Ther. 2021;21:499\u2013507.","journal-title":"Expert Opin Biol Ther"},{"key":"2308_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1055\/a-1069-0900","volume":"74","author":"H Timmermann","year":"2020","unstructured":"Timmermann H, Mail\u00e4nder C. Home self-administration of biologics: a German survey among omalizumab-treated oatients with severe asthma and their treating physicians. Pneumologie. 2020;74:103\u201311.","journal-title":"Pneumologie"},{"key":"2308_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186458","volume":"12","author":"L N\u00e1fr\u00e1di","year":"2017","unstructured":"N\u00e1fr\u00e1di L, Nakamoto K, Schulz PJ. Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PLoS ONE. 2017;12: e0186458.","journal-title":"PLoS ONE"},{"key":"2308_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027475","volume":"9","author":"A Tonna","year":"2019","unstructured":"Tonna A, Anthony G, Tonna I, et al. Home self-administration of intravenous antibiotics as part of an outpatient parenteral antibiotic therapy service: a qualitative study of the perspectives of patients who do not self-administer. BMJ Open. 2019;9: e027475.","journal-title":"BMJ Open"},{"key":"2308_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/msc.114","volume":"6","author":"J Hiley","year":"2008","unstructured":"Hiley J, Homer D, Clifford C. Patient self-injection of methotrexate for inflammatory arthritis: a study evaluating the introduction of a new type of syringe and exploring patients\u2019 sense of empowerment. Musculoskelet Care. 2008;6:15\u201330.","journal-title":"Musculoskelet Care"},{"key":"2308_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/PPA.S118107","volume":"11","author":"M Munsell","year":"2017","unstructured":"Munsell M, Frean M, Menzin J, Phillips AL. An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug. Patient Prefer Adher. 2017;11:55\u201362.","journal-title":"Patient Prefer Adher"},{"key":"2308_CR17","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1111\/bjd.15074","volume":"175","author":"S Denman","year":"2016","unstructured":"Denman S, Ford K, Toolan J, et al. Home self-administration of omalizumab for chronic spontaneous urticaria. Br J Dermatol. 2016;175:1405\u20137.","journal-title":"Br J Dermatol"},{"key":"2308_CR18","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/jdv.15045","volume":"32","author":"M Ghazanfar","year":"2018","unstructured":"Ghazanfar M, Holm J, Thomsen SF. Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study. J Eur Acad Dermatol Venereol. 2018;32:1761\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2308_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.anai.2020.05.029","volume":"125","author":"M Greenhawt","year":"2020","unstructured":"Greenhawt M, Shaker M. Keeping risk in context while rethinking the setting of asthma biologics in patient-centered care. Ann Allergy Asthma Immunol. 2020;125:124\u20135.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2308_CR20","first-page":"565","volume":"8","author":"M Shaker","year":"2020","unstructured":"Shaker M, Briggs A, Dbouk A, Dutille E, Oppenheimer J, Greenhawt M. Estimation of health and economic benefits of clinic versus home administration of omalizumab and mepolizumab. J Allergy Clin Immunol. 2020;8:565\u201372.","journal-title":"J Allergy Clin Immunol"},{"key":"2308_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.anai.2020.06.030","volume":"125","author":"DA Bukstein","year":"2020","unstructured":"Bukstein DA, Guerra DG Jr, Huwe T, Davis RA. A review of shared decision-making: a call to arms for health care professionals. Ann Allergy Asthma Immunol. 2020;125:273\u20139.","journal-title":"Ann Allergy Asthma Immunol"}],"updated-by":[{"DOI":"10.1007\/s12325-022-02373-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000}}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02308-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T17:36:39Z","timestamp":1674236199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02308-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2308"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02308-w","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"2 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12325-022-02373-1","URL":"https:\/\/doi.org\/10.1007\/s12325-022-02373-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}